TY - JOUR
T1 - The Arenaviridae Family
T2 - Knowledge Gaps, Animal Models, Countermeasures, and Prototype Pathogens
AU - Hastie, Kathryn M.
AU - Melnik, Lilia I.
AU - Cross, Robert W.
AU - Klitting, Raphaëlle M.
AU - Andersen, Kristian G.
AU - Saphire, Erica Ollmann
AU - Garry, Robert F.
N1 - Publisher Copyright:
© 2023 The Author(s). Published by Oxford University Press on behalf of Infectious Diseases Society of America. All rights reserved.
PY - 2023/10/15
Y1 - 2023/10/15
N2 - Lassa virus (LASV), Junin virus (JUNV), and several other members of the Arenaviridae family are capable of zoonotic transfer to humans and induction of severe viral hemorrhagic fevers. Despite the importance of arenaviruses as potential pandemic pathogens, numerous gaps exist in scientific knowledge pertaining to this diverse family, including gaps in understanding replication, immunosuppression, receptor usage, and elicitation of neutralizing antibody responses, that in turn complicates development of medical countermeasures. A further challenge to the development of medical countermeasures for arenaviruses is the requirement for use of animal models at high levels of biocontainment, where each model has distinct advantages and limitations depending on, availability of space, animals species-specific reagents, and most importantly the ability of the model to faithfully recapitulate human disease. Designation of LASV and JUNV as prototype pathogens can facilitate progress in addressing the public health challenges posed by members of this important virus family.
AB - Lassa virus (LASV), Junin virus (JUNV), and several other members of the Arenaviridae family are capable of zoonotic transfer to humans and induction of severe viral hemorrhagic fevers. Despite the importance of arenaviruses as potential pandemic pathogens, numerous gaps exist in scientific knowledge pertaining to this diverse family, including gaps in understanding replication, immunosuppression, receptor usage, and elicitation of neutralizing antibody responses, that in turn complicates development of medical countermeasures. A further challenge to the development of medical countermeasures for arenaviruses is the requirement for use of animal models at high levels of biocontainment, where each model has distinct advantages and limitations depending on, availability of space, animals species-specific reagents, and most importantly the ability of the model to faithfully recapitulate human disease. Designation of LASV and JUNV as prototype pathogens can facilitate progress in addressing the public health challenges posed by members of this important virus family.
KW - animal models
KW - arenaviruses
KW - countermeasures
KW - knowledge gaps
KW - prototype pathogen
UR - http://www.scopus.com/inward/record.url?scp=85174748881&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85174748881&partnerID=8YFLogxK
U2 - 10.1093/infdis/jiac266
DO - 10.1093/infdis/jiac266
M3 - Article
C2 - 37849403
AN - SCOPUS:85174748881
SN - 0022-1899
VL - 228
SP - S359-S375
JO - Journal of Infectious Diseases
JF - Journal of Infectious Diseases
ER -